The header image of drawings for a Patent application is courtesy of Getty Images, ThoughtCo, and Google Images.

Health Friday is a series devoted to information about Big Pharma, general health, and associated topics. As today’s offering speaks to the disaster of COVID-19, Yours Truly dedicates it to all persons, of whatever age or location, who have suffered health issues from to an infection of the COVID-19 virus itself; or, from the negative effects of the COVID-19 “vaccines” that they have in their bodies; or, who have passed away from complications due to an infection of the COVID-19 virus itself, or from complications due to the negative effects of the COVID-19 “vaccines” they had in their bodies.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated content. To the best of her knowledge and belief, there is none, except for AI-generated images and/or text within linked URLs. If readers wish to post AI-generated content to today’s discussion thread, they must cite their source. Thank you.

Yours Truly wishes one and all a Happy New Year 2026.

Special Note regarding today’s offering: In no way is the following, or The Baric Files in general in the Health Friday posts, to be construed as a “character assassination”, or as an “indictment”, or as any other type of attack or smear on the Ralph Baric, PhD, of the UNC Gillings School of Global Public Health of the University of North Carolina, Chapel Hill, or of his lab at the university. The linked scientific papers, images therefrom, and other information about Dr. Baric (such as, his Curriculum Vitae [1]) are all available on the internet. The ideas and conclusions of today’s offering are by Yours Truly. There is a plethora of information related to Dr. Baric; Yours Truly will focus on a few of them in each part of The Baric Files.

Today’s offering is Part Three of six. For other information regarding Dr. Baric, please see: https://www.theqtree.com/2025/12/05/health-friday-12-5-2025-open-thread-the-baric-files-part-one/; and, https://www.theqtree.com/2025/12/12/heatlh-friday-12-12-2025-open-thread-the-baric-files-part-two-of-mice-rabbits-and-ai-23946/.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The Baric Files, Part Three: Patents; Dr. Anthony Fauci

Patents:

Ralph S. Baric, PhD, owns 25 to 30 Patents (depending on whether one is looking at, for example, https://justia.com/patents/, or at https://patents.google.com/, or at NIH RePorter at https://report.nih.gov/) related to items he found or created during his research journey into coronaviruses and/or his Gain-of-Function experiments. What is definite, however, is that our old friend, NIH grant AI23946 (also called AI023946) figures in at least three of these Patents: Patent Number 6593111; Patent Number 7279327; and, Patent Number 7618802 — all of which are associated with his lab the UNC Gillings School of Global Public Health at the University of North Carolina Chapel Hill.

Patent Number 6593111 is titled, “Directional assembly of large viral genomes and chromosomes.”

Patent Number 7279327 is titled, “Methods of Producing Recombinant Coronaviruses.”

Patent Number 7618802 is titled, “Methods and compositions for infectious cDNA of SARS coronavirus.”

Yours Truly will focus on Patent Number 6593111 [2], the timeline of which Patent begins on 5 May 2001. The NIH grant AI023946 has been “extended” several times; in this Patent, it is called “AI023946-08“, and the Patent Number has been changed to “US6593111B2.” By now, Dr. Baric’s research journey has taken him to experimenting with coronaviruses that infect pigs: in particular, the TGE virus (Transmissible Gastroenteritis virus, also called Transmissible Gastroenteritis Coronavirus [TGEV].) The following screenshots are from the Patent document. The screenshots are, in order: the Abstract; the Events summary; the first paragraph of the Summary of the Invention section; from the Detailed Description of the Preferred Embodiments discussion section; and, Fig. 1a and Fig. 2 from the images in the Patent document:

Note, in the screenshot above, the mention of “vaccines and expression vectors”; and, the sentence, “The vectors may be targeted to other species by, for example, replacing the S glycoprotein gene.” This paragraph, in Yours Truly’s’ opinion, begins the eventual “tie-into evolution” of the SARS-CoV-2 virus. In other words — Gain-of-Function research and application.

However, there is another item in Patent Number US6593111B2 that is interesting: the list of Legal Events near the end of the document. A screenshot of this list is below:

Note that UNC (Baric lab) “transferred” the ownership of the Patent to the NIH in 2008. Note also that on 18 January 2011, someone at NIH must have sent the Patent Fee payment that would be good for eight years. A Fee payment for a Patent is a “Patent Maintenance Fee” that “preserve a patent.” [3] Note also, that on 15 January 2015, someone at NIH must have sent the Patent Fee payment that would good for twelve years (thus theoretically preserving the Patent until January 2027.) However, on the Events Summary list for Patent Number US6593111B2 (in the images above), it lists the Patent as Status Expired – Lifetime. This brings up some questions: To what person at NIH was Patent US6593111 transferred to in 2008? The NIH Director in June 2008 was Elias Zerhouni, MD [4]. When he left the NIH, who did he designate to take over NIH ownership of the Patent? Is Patent US6593111B2 still in force, even though it is listed as “Status Expired – Lifetime?” Is it still in force, but under a different name?

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Anthony Fauci, MD, Director of NIAID 1984 – 2022:

It can be assumed that Dr. Ralph Baric, PhD, had been on the “radar” of Dr. Anthony Fauci, MD, Director of the NIAID division (National Institute of Allergy and Infectious Diseases division) of the National Institutes of Health (NIH) since at least 1984, if not before (Dr. Fauci had joined NIH in 1968, shortly after completing his medical Residency.) This “being on his radar” situation, in Yours Truly’s opinion, would have included, at the least, what may be called a “bowing acquaintance” with Dr. Baric through NIAID funding applications and grants dispersements reports.

In fact, NIH / NIAID (and, it can be assumed, within the knowledge of Dr. Anthony Fauci), was funding Dr. Barics’s Gain-of-Function research on coronaviruses as far back as at least the year 2003 [5]. The 2003 paper not only describes what can only be called Gain-of-Function experiments with SARS coronaviruses; it also describes the Baric-invented “No see ‘m” procedure for covering up gene code insertions in the lab-creation of SARS coronavirus “clone” viruses. Please see the screenshots from this paper, below. Note that our old friend, NIH grant AI23946, was involved in the funding of the 2003 paper. Below are: the Abstract, the Figure 1., and, the Acknowledgements sections from this paper:

Note that one of the co-authors of the 2003 paper is Thomas M. Geisbert, of the the United States Army Medical Research Institute of Infectious Diseases (also known as USAMRIID, located at Fort Detrick, Maryland.)

Another example of NIH / NIAID / Dr. Anthony Fauci funding Gain-of-Function research by Dr. Baric is NIH grant R01AI059136-04, from 2004 [6]. Please see the screenshots from the documents on this grant, below: of the Title for the grant; the Abstract; the Funding Agency; and, the receiving Institution:

Dr. Fauci has denied ever knowing Dr. Baric. However, there is evidence to the opposite: Please see the screenshots, below, from a February 2023 U.S. Right to Know article by Emily Kopp [7]:

A screenshot of a photo from the Emily Kopp article:

The official work calendar for Dr. Anthony Fauci was released via FOIA from Open The Books [8]. The calendar shows that Dr. Fauci met with Dr. Baric in February 2020. A screenshot from the article in Open The Books on this situation is below:

An article by Sainath Suryanarayanan in U.S. Right to Know related to Dr. Baric’s emails early in the COVID-19 pandemic [9]. These emails were either from Dr. Baric, or were sent to him as part of a group email from various institutions and/or government agencies and/or from medical professionals in these institutions or agencies. In these emails, the “code name” for the burgeoning COVID-19 virus infection situation in the United States was “Red Dawn Responding, Start 16 March.” The emails were released through a public records request.

By the way, Dr. Baric and his lab at the University of North Carolina Chapel Hill worked with Gilead Sciences to create remdesivir (Veklury), a COVID-19 treatment drug that can have a mortality rate of 50%, and also can cause kidney damage [10] [11] [12] [13]. Please see the screenshots below; the first, from the University of North Carolina article about the creation of remdesivir; the others are also items regarding this drug:

Please see Reference [10].

Veklury Package Insert,Warnings and Precautions:

Please see Reference [11].

Please see Reference [12].

World Health Organization (WHO) advisory against using Veklury (remdesivir):

Please see Reference [13].

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

It is apparent that by at least the year 2003, Dr. Baric’s research journey was shifting to methods and applications for the cloning of coronaviruses, including his invention of the “No see ‘m” method of covering up insertions into coronavirus gene code pieces in the lab-creation of the cloning of coronaviruses to make such insertions “un-traceable.”

To be continued in The Baric Files: Part Four.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

ALL COVID-19 “VACCINES” MUST BE REMOVED FROM THE MARKET AND FROM USE IN THE UNITED STATES. NOW.

ALL GAIN-OF-FUNCTION RESEARCH ACTIVITIES IN THE UNITED STATES MUST BE STOPPED AND DE-FUNDED. NOW.

THERE. MUST. BE. ACCOUNTABILITY.

THERE. MUST. BE. JUSTICE.

THERE. MUST. BE. TRUTH.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Notice and Disclaimer: With the exception of published scientific papers, news articles, and other items available on the internet, the ideas and conclusions of today’s offering are by PAVACA. Proper credit must be given to PAVACA if the ideas and conclusions in today’s offering are used by other blog writers, podcasters, in social media, or in print media.)

References:

[1]: “Curriculum Vitae Ralph S. Baric”. https://sph.unc.edu/wp-content/uploads/sites/112/2016/09/CV_Ralph_Baric.pdf. 2016.

[2]: “Directional Assembly Of Coronavirus Infectious Clones”. https://patents.google.com/patent/US6593111B2/en. Ralph S. Baric, Boyd Yount.

[3]: “Patent Maintenance Fees – Must be paid to preserve a patent.” https://sierraiplaw.com/patent-maintenance-fees, 2023 Sierra IP.

[4]: “Elias Zerhouni.” https://en.wikipedia.org/wiki/Elias_Zerhouni.

[5]: “Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.” https://www.pnas.org/cgi/doi/10.1073/pnas.1735582100. Ralph S. Baric, Thomas Geisbert, et al. 29 August 2003.

[6]: “SARS Reverse Genetics.” https://grantome.com/grant/NIH/R01-AI059136-04.

[7]: US Right to Know. https://usrtk.org/covid-19-origins/fauci-discussed-gain-of-function-work-with-wuhan-collaborator-in-pandemics-earliest-days-emails-suggest/. Emily Kopp. 21 February 2023.

[8]: Open the Books. https://www.openthebooks.com/substack-historic-release-dr-anthony-faucis-official-work-calendar-november-2019-march-2020/. Adam Andrzejewski. 20 October 2022.

[9]: US Right to Know. “Items from coronavirus expert Ralph Baric’s emails.” https://usrtk.org/covid-19-origins/ralph-baric-emails/. Sainath Suryanarayanan. 14 December 2020.

[10]: “Remdesivir developed through a UNC-Chapel Hill partnership proves effective against COVID-19 in NIAID human clinical trials.” https://sph.unc.edu/sph-news/remdesivir-developed-at-unc-chapel-hill-proves-effective-against-covid-19-in-niaid-human-clinical-trials/. 29 April 2020.

[11]: “Veklury Package Insert.” https://www.gilead.com/-/media/files/pdfs/medicines/covid-19/veklury/veklury_pi.pdf. Veklury is the marketing name for remdesivir.

[12]: “BREAKING — The Pandemic Justice Phase Begins as Criminal Investigations Commence.” https://www.thefocalpoints.com/p/breaking-the-pandemic-justice-phase. Nicolas Hulscher. 18 April 2025.

[13]: “FDA Approves Remdesivir in Kidney Patients after Failed Trial.” https://www.thefocalpoints.com/p/fda-approves-remdesivir-in-kidney. Dr. Peter A. McCullough, MD, MPH. 21 July 2023.